To improve the predictive accuracy of the signal-averaged electrocardiogram, we created a linear logistic model for predicting ventricular tachycardia during electrophysiologic testing. This signal-averaged electrocardiographic model was created from data obtained from 214 patients undergoing electrophysiologic testing (70 had ventricular tachycardia during electrophysiologic testing) by using stepwise logistic regression to rank eight clinical and nine signal-averaged electrocardiographic variables. The 
same patients is likely to be successfully replicated in a prospective study because of its verification by cross validation.
Methods

Patient Population
The study group consisted of 274 patients who underwent signal-averaging ECG before electrophysiologic testing between February 17, 1986, and October 1, 1987 . The patients underwent electrophysiologic testing because of syncope (146 patients), complex ventricular ectopy (83 patients), ventricular tachycardia (21 patients), wide complex tachycardia (15 patients), or out-of-hospital cardiac arrest (nine patients). No patient had bundle branch block or accessory pathway. Although some patients were excluded, this population is representative of patients undergoing electrophysiologic testing and of patient groups studied by other investigators using ECG signal-averaging techniques.3'6'7 All antiarrhythmic drugs were discontinued for 5 half-lives before the signal-averaging session.
Patients were examined by a staff cardiologist and underwent the following tests: standard posteroantero chest roentgenography, 12-lead ECG, vectorcardiography, cardiac angiography to measure ejection fraction, radionuclide angiography or echocardiography, and long-term ECG monitoring by an in-hospital system or a Holter system. The type of heart disease present was evaluated in the patients. Sixty patients had normal cardiac function and vasculature, and 214 had cardiac abnormalities as follows: coronary artery disease (149 patients), dilated cardiomyopathy (40 patients), mitral valve prolapse (18 patients), valvular heart disease (five patients), congenital heart disease (one patient), and hypertrophic obstructive cardiomyopathy (one patient).
Patients were classified as having coronary disease by either a documented previous myocardial infarction or the presence of narrowing (>70%) of one or more coronary arteries based on coronary angiography. The classification of dilated cardiomyopathy was made when there was global left ventricular dysfunction with an impaired ejection fraction (<50%) and normal coronary arteries (<50% narrowing) based on angiography. A classification of mitral valve prolapse was made when this was the only significant cardiac diagnosis by the patient's staff cardiologist (based on physical examination or echocardiography). In the remaining seven patients, the classifications of valvular heart disease, congenital heart disease, and hypertrophic obstructive cardiomyopathy were based on echocardiography or cardiac angiography in addition to physical examination.
Signal Averaging
Standard skin preparation before each signalaveraging session consisted of shaving, removing excess skin oil with alcohol, and abrading the skin mildly with cotton gauze. All studies were performed in the patient's hospital room. Unnecessary electrical equipment was disconnected to minimize 60-Hz interference.
Instrumentation
A bipolar x,y,z lead system was used with a reference lead placed over the right lower abdomen. The incoming signal from each lead was amplified and converted into a digital formal (16- 
Signal Processing
The averaged QRS complexes were filtered with fourth-order bidirectional high-pass filters at settings of 25, 40, and 80 Hz. After filtering, the total QRS duration was determined by a computer algorithm described elsewhere.3 After determination of QRS onset and offset, the computer calculated the QRS duration, root mean square (RMS) voltage in the terminal 40 msec of the QRS complex, and the duration of low-amplitude signals (<40 pV) at the terminal QRS complex. Each of these measurements was obtained after 25-, 40-, and 80-Hz high-pass filtering.
Electrophysiologic Evaluation
All patients had been in the drug-free state during the 24 hours of ECG monitoring by the Holter system or an in-hospital monitoring system. Patients who underwent in-hospital monitoring had qualitative but not quantitative evidence of ectopy. To maintain consistency, long-term monitoring was evaluated for either the presence or absence of ventricular ectopic pairs of nonsustained ventricular tachycardia. Nonsustained ventricular tachycardia was defined as three or more consecutive ventricular complexes at a rate greater than 110 beats/min.
In our electrophysiology laboratory, the standard protocol for ventricular stimulation consists of delivering single, double, and triple ventricular extrastimuli at twice diastolic threshold while scanning diastole when the patient is in sinus rhythm as well as during ventricular pacing at 100 and 150 beats/min at the right ventricular apex and the right ventricular outflow tract. An electrophysiologic test is considered to be positive when sustained monomorphic ventricular tachycardia is induced. Sustained monomorphic ventricular tachycardia is defined as Diagnostic Criterion To choose a diagnostic criterion for the signalaveraged ECG model, we plotted data from the 214 patients according to the electrophysiologic test results and the log-odds given by the linear combination equation (Figure 1 ). Probability thresholds from 10% to 50% were evaluated as to how well they distinguished patients with from those without ventricular tachycardia during electrophysiologic testing. Any patient whose linear combination falls to the left of a given probability threshold has less than that probability of ventricular tachycardia during electrophysiologic testing; the converse holds for patients falling to the right of a given threshold. Sensitivities, specificities, and predictive accuracies at the various probability thresholds are shown in Table 4 . After examining the probability thresholds from 10% to 50%, we decided that, to maximize sensitivity for this noninvasive test with acceptable specificity, a 10% probability threshold provided the most desirable predictions.
Cross Validation
When the same patients from whom a predictive model was In this analysis, the sample of 214 patients with heart disease was divided into 10 roughly equal subsets on the basis of the last digit of their patient registration numbers. Stepwise logistic regression was applied to a sample of nine of these 10 subsets.
The resulting model was used to compute probabilities for the remaining subset and to classify these patients (at the 10% probability threshold). This was repeated nine times, leaving out each of the 10 subsets in turn. Thus, each patient ultimately received a predictive classification based on a rule obtained independently of that patient. The crossvalidated rates obtained in this way reflect how the overall model, based on 214 patients, will perform when applied to future patients. These crossvalidated rates underestimate the specificity of the model because patients with normal hearts will likely be studied clinically, though not in this study.
Comparison With Established Criteria
Sensitivities of the model before and after cross validation were 94% and 91%, respectively; the established 25 -Hz criteria give a 64% sensitivity, and the 40-Hz criteria give an 84% sensitivity ( than that of established criteria. Moreover, there was no significant decrease in the model's specificity before and after cross validation (62% and 59%, respectively). The specificity of the model was an improvement over the specificity of the 40-Hz criteria. Although the specificity of the model is less compared with that of the 25-Hz criteria, this decrease is offset by the model's much greater sensitivity. The most appealing feature of the signalaveraged ECG model is its very high negative predictive accuracy before (96%) and after (93%) cross validation. This compares favorably with established criteria (Table 5) . Further analysis separated patients into two groups, 149 with and 65 without coronary artery disease. During electrophysiologic testing, there were 58 patients with coronary artery disease and 12 patients without coronary artery disease with inducible ventricular tachycardia. In patients with coronary artery disease, the model's sensitivity before (96%) and after (93%) cross validation improved over the sensitivities with 25-(69%) and 40-Hz (88%) criteria (Table 6 ). Although the model's specificity was not as great as that with the 25-Hz criteria, this was by design because a high negative predictive accuracy was sought in creation of the model. The model's negative predictive accuracies before (96%) and after (92%) cross validation outperformed the other criteria.
Another strength of the model was demonstrated in patients without coronary artery disease. The model had better sensitivities, specificities, and positive and negative predictive accuracies ( Table  6) . The model had a high sensitivity before (83%) and after (83%) cross validation, and specificity Present  69  86  76  81  Absent  42  83  36  86  40-Hz filtering  Present  88  50  53  87  Absent  67  59  27  89  Model  Present  96  52  56  96  Absent  83  80  48  96  Cross-validated model  Present  93  54  56  92  Absent  83  68  37  95 specificity, and for this, the 10% probability threshold offered the most desirable predictive accuracy. Falsenegative results must be minimal if results of the noninvasive signal-averaged ECG are to be used for screening purposes and in clinical decisions regarding possible ventricular tachycardia patients. A limitation of this study is that the model was derived from and tested on the same 214 patients. Although cross validation reinforced the results, the best validation would come from a prospective study. We could have created the model from a segment of our study group and tested the model on the remainder, but we chose to use the power of a larger patient population to create the model and to use cross validation to reinforce the result. Cross validation is an acceptable method of analysis in such a situation.10-12 Only patients with heart disease were evaluated by cross validation. Sixty patients were classified as having an absence of heart disease, and none of these patients had ventricular tachycardia induced during electrophysiologic testing. The low, or absent, inducibility of ventricular tachycardia during electrophysiologic testing in patients without clinical heart disease has been reported previously.21-23 These patients were not used in the logistic regression or in assessing the relative performance of the model. The cross-validated rates will underestimate the specificity of the model because patients with normal hearts will likely be studied clinically.
Another limitation of this study is the use of electrophysiologic testing as the reference standard. Although electrophysiologic testing has been found to be predictive of subsequent prognosis,24-26 clinical follow-up would be the true standard (especially in patients without coronary artery disease).
In this study, the signal-averaged ECG was found to be predictive of ventricular tachycardia. By incorporating signal-averaged ECG variables and clinical variables in the signal-averaged ECG model, we improved the predictive ability of the signal-averaged ECG. The use of this linear logistic equation in an interactive software program will improve the clinician's ability to evaluate patients noninvasively for ventricular tachycardia and to determine which patients will benefit from invasive testing. 
